Tencent ‘exploring’ a financial holding company for WeChat Pay if Chinese regulators require it

Tencent ‘exploring’ a financial holding company for WeChat Pay if Chinese regulators require it


An image of WeChat Pay in action.

Zhang Peng | LightRocket | Getty Images

Chinese tech giant Tencent is exploring whether regulators will require it to create a financial holding company to house is fintech business, a top executive said on Wednesday.

The comments come after Bloomberg reported last week that Chinese authorities are considering requiring Tencent to include WeChat Pay, its ubiquitous mobile payments service, in a new financial holding company.

“We have been continuously exploring the establishment of the financial holding company and looking at the regulation with respect to that and whether there is a requirement for that,” Tencent President Martin Lau said on an earnings call with media Wednesday, after the firm posted its slowest revenue growth on record.

Bloomberg, citing people familiar with the matter, reported that Tencent needs to place its banking, securities, insurance and credit-scoring services into a financial holding company that can be regulated like a traditional bank.

The People’s Bank of China, the country’s central bank, has long been concerned about technology companies operating banking-like services and the perceived risks that come with that to financial stability. Tencent, via messaging app WeChat, offers services from payments to microloans. WeChat has over 1.2 billion monthly active users.

In November, regulators suspended the public listing of Ant Group, which would have been the world’s largest, over regulatory concerns. The PBOC has asked Ant Group, which is the financial technology affiliate of e-commerce giant Alibaba, to restructure as a financial holding company.

This month, the Chinese central bank approved the establishment of two financial holding companies.

Tencent’s Lau said the internet giant was watching this development closely for guidance.

“Recently there have been two financial holding company licenses that have been issued. We felt after that we should have a clearer picture on what are the criteria for inclusion into financial holding company and whether we qualify or not,” Lau said. “We are proactively engaging in that discussion.”

The Tencent president said that the regulators are trying to “guide a healthier and more sustainable development” of the financial industry.

Setting up a financial holding company would “involve some organizational changes” but Tencent would be able to comply and it should not impact the business, Lau added.



Source

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks
Finance

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks

Key Points Kevin Hassett told Fox Business that U.S. banks could voluntarily provide credit cards to underserved Americans. President Donald Trump called for banks to cap credit card interest rates at 10%, an idea that has been roundly rejected by industry executives and their lobbyists this week. At least one major credit card issuer and […]

Read More
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]

Read More
Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more
Finance

Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more

Check out the companies making headlines before the bell. ImmunityBio — The biotech company rallied 22%, adding to a 30% rally in the previous session that was sparked by strong guidance for its bladder cancer drug Anktiva. ImmunityBio expects full-year revenue for the drug to jump 700%. Coupang — Shares rose more than 3% after […]

Read More